Our present analysis establishes a highly significant and robust correlation between DDR2 expression and neuroblastoma patient outcome in 9 out of 10 patient datasets, ranking on the top of our list together with RET (Fig. 2 top subset and Fig. 4a). The gene discussed is DDR2; the disease is neuroblastoma.